- Researchers studied GLP‑1 drugs and addiction.
- These drugs first treated type 2 diabetes in patients.
- Many people also use them for weight loss.
- Some patients said they lost interest in alcohol.
- Others said they wanted less nicotine and cigarettes.
- The study looked at many US veterans with diabetes.
- GLP‑1 users had fewer new addiction problems.
- For people with addiction, harms were smaller.
- Scientists think the drugs reduce craving in the brain.
Difficult words
- researcher — person who studies and checks factsResearchers
- addiction — strong need to use a drug or substance
- diabetes — long illness with high blood sugar
- veteran — person who served in the militaryveterans
- craving — very strong desire to have something
- harm — physical or other damage or hurtharms
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you or someone you know used drugs for weight loss?
- Do you drink alcohol?
- Do you smoke cigarettes?
Related articles
Genes linked to chronic kidney disease
Researchers led by Alejandro Chade at the University of Missouri studied genes involved in chronic kidney disease using animal models. They found genes linked to kidney damage; silencing one gene lowered fibrosis. The team will map and test gene activity.
Virtual diet and exercise program helps people with lymphoma
A study tested a virtual diet and exercise program for people getting chemotherapy for lymphoma. The program improved symptoms, attendance was high, and participants had better strength and physical performance during treatment.
FDA approves bemotrizinol for US sunscreens
The Food and Drug Administration approved the sunscreen ingredient bemotrizinol for use in the United States. The ingredient blocks UVA and UVB rays; when it appears in products will depend on reformulation, testing and marketing by companies.